Matsuoka M, Hattori T, Nishimura Y, Takatsuki K
Second Department of Internal Medicine, Kumamoto University School of Medicine, Japan.
Leukemia. 1995 Aug;9(8):1338-43.
Adult T cell leukemia (ATL) cells show the decreased expression of T cell receptor (TCR)/CD3 complex on their surfaces in vivo. It is well known that excess amounts of antigen modulate TCR/CD3 complex on antigen-specific T lymphocytes. We hypothesized that antigen receptor of ATL cells was down-regulated with some antigenic stimulation in vivo, which might play an important role in leukemogenesis. In order to test this possibility, we studied whether the fresh ATL cells from three cases would respond to autologous and allogeneic lymphoid cell lines. In two of three cases, ATL cells could proliferate in the presence of autologous cell lines. In one case, this proliferation could be completely inhibited by anti-CD3 and anti-human leukocyte antigen (HLA)-DQ monoclonal antibodies, indicating that ATL cells recognized self HLA-DQ. In another case, the proliferation was suppressed by anti-CD3 and HLA-DR antibodies. These findings showed that ATL cells of some cases were derived from autoreactive T lymphocytes and such stimulation via TCR/CD3 complex plays an important role in the leukemogenesis of ATL in vivo.
成人T细胞白血病(ATL)细胞在体内其表面的T细胞受体(TCR)/CD3复合物表达降低。众所周知,过量的抗原会调节抗原特异性T淋巴细胞上的TCR/CD3复合物。我们推测,ATL细胞的抗原受体在体内受到某些抗原刺激后会下调,这可能在白血病发生过程中起重要作用。为了验证这种可能性,我们研究了来自3例患者的新鲜ATL细胞是否会对自体和同种异体淋巴细胞系产生反应。在3例中的2例中,ATL细胞在自体细胞系存在的情况下能够增殖。在1例中,这种增殖可被抗CD3和抗人白细胞抗原(HLA)-DQ单克隆抗体完全抑制,表明ATL细胞识别自身HLA-DQ。在另一例中,增殖被抗CD3和HLA-DR抗体抑制。这些发现表明,部分病例的ATL细胞源自自身反应性T淋巴细胞,并且通过TCR/CD3复合物的这种刺激在体内ATL的白血病发生中起重要作用。